摘要
目的:探讨高血压患者脉压与尿微量白蛋白(UmALB)排泄量的关系。方法:选取80例原发性高血压患者,据脉压(PP)水平分成PP<9.33 kPa组38例和PP≥9.33 kPa组42例。两组均予系统降压治疗1月,血压达标(BP<18.67/12 kPa)后注意观察3月,分析这些患者治疗前后PP及UmALB的变化,并进行比较。结果:PP<9.33 kPa组治疗前后UmALB量无明显变化,PP≥9.33 kPa组治疗后有37例血压达标,该组总的UmALB分泌量减少,其中治疗后PP<9.33 kPa组病例比治疗后PP≥9.33 kPa组病例的UmALB的分泌量明显减少(P<0.05)。结论:随着脉压的降低,尿微量白蛋白排泄量显著下降,故脉压增大是高血压患者早期肾功能损害的预测因素。
Objective:To disscuss the relationship between pulse pressure(PP) and excretion of urinary microprotion(UmALB) in patients with essential hypertension. Methods: To select 80 patients with essential hypertension, to divide into two groups according to the PP level. One had 38 patients PP 〈 9.33 kPa,the other had 42 patients with PP ≥9.33 kPa,All patients of two groups were given the same normal treatment for one month. After the blood pressure(BP) normal( BP 〈 18.67/12 kPa) to continuous observe 3 monthes. Results: There was no obvious change about the UmALB in PP 〈 9.33 kPa group before and after treatment. After the treatment there were 37 cases who's BP reach the normal in the group of PP≥9.33 kPa , the total UmALB excretion reduced. The UmALB excretion of PP 〈 9.33 kPa group was less than PP ≥ 9.33 kPa group after treatment, the difference was remarkable ( P 〈 0. 05 ). Conclusions: With the PP reduction, UmALBs excretion drops, therefore, the increase of PP is a predictor of early renal damage.
出处
《现代临床医学》
2008年第3期170-171,共2页
Journal of Modern Clinical Medicine
关键词
高血压
脉压
尿微量白蛋白
hypertension
pulse pressure
urinary microalbuminuria